Viable surgery for advances in Cancer of the Prostate study finds (HealthDay)

surgery to remove the prostate (radical prostatectomy) leads to a survival rate of 20 to 80 per cent of patients with advanced prostate cancer, a new study concludes.

The study involved patients with cancer that has spread beyond the prostate, known as the cT3 prostate cancer and has undergone a radical prostatectomy between 1987 and 1997.

Survival of 80 per cent of these patients is comparable to a survival rate of 90% at 20 years for patients with cancer confined to the prostate (cancer of the prostate cT2), said Mayo Clinic researchers.

Previously, the authors of the study of patients with cancer of the prostate cT3 were offered to strike out or hormone therapy, but not radical prostatectomy, noted in a press release of Mayo.

"We're a much better job of identifying and expansion of the candidates for the surgery, which translates into longer, better results for both of our patients," Dr. r. Jeffrey Karnes, urology department, said in the press release.

The study was scheduled for the presentation of May 15 at the annual meeting of the American Urological Association, Washington, D.C. presented research at meetings is considered preliminary until published in a refereed journal.